Topic resource collection
Approved comparison material connected to this topic.
6 resourcesRead both sides
Cerebrolysin NGF/BDNF mimetic; TrkB receptor activation 30+ RCTs; Cochrane review meta-analysis 10–30mL IV daily for 10–20 days Approved in 44 countries; not FDA-approved Strongest human evidence base; requires IV administration …
The fundamental misconception about cognitive peptides is that they 'boost brain power' as a vague, generalised effect. They don't. Each peptide targets a specific receptor system: Cerebrolysin contains neurotrophic peptides that…
The gap between 'works in rodents' and 'FDA-approved for human cognitive enhancement' is vast. Cerebrolysin has 30+ years of clinical use in Europe and Asia for stroke recovery and dementia. Regulatory approval exists in 44 count…
Dihexa HGF receptor agonist → BDNF upregulation 1–5mg/mL Daily Morning (6–10 AM) Best for learning and memory consolidation tasks; 7× more potent than BDNF in synaptogenesis studies Cerebrolysin NGF-mimetic neuropeptide blend Pre…
Cerebrolysin BDNF, NGF, CNTF upregulation 5–10ml IM/IV, 5 days/week, 4–8 weeks Measurable at week 3–4 High (multiple RCTs, 1,200+ patients) Gold standard for post-stroke and TBI recovery; strongest human data Dihexa HGF receptor …
Selank vs Semax compared head-to-head: mechanisms, dosage, effects, and when to use each. Both developed at Russia's Institute of Molecular Genetics.